Literature DB >> 21281981

Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection.

Julio Granados-Montiel1, Joaquin Zúñiga, Jose Azocar, Edmond J Feris, Daniel Terreros, Charles E Larsen, Olga P Clavijo, Alfredo Cruz-Lagunas, Derek Middleton, Chester A Alper, Janardan P Pandey, Edmond J Yunis.   

Abstract

Genetic interactions between natural killer (NK) cells immunoglobulin-like receptor (KIR) genes and immunoglobulin allotypes have been previously reported in type 2 diabetes mellitus (DM) patients. Puerto Rican Americans with a history of intravenous drug use who developed DM following HCV infection (n=32) were compared to individuals infected with HCV without diabetes (n=121) and to DM non-infected individuals (n=95). Subjects were genotyped for KIRs and immunoglobulin allotypes. We found interactions of immunoglobulin allotypes KM3/KM3 with NK inhibitory receptors 2DL3/2DL3, 2DL1 in the absence of 2DS4 associated with susceptibility to DM in HCV infected individuals. These data suggest the possibility that a subset of patients with HCV could have an immune-mediated component contributing to the development of DM.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21281981      PMCID: PMC3089690          DOI: 10.1016/j.imbio.2010.10.006

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  35 in total

1.  Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican Americans.

Authors:  Joaquin Zuniga; Viviana Romero; Jose Azocar; Joel N H Stern; Olga Clavijo; Ingrid Almeciga; Liliana Encinales; Angel Avendano; Masha Fridkis-Hareli; Janardan P Pandey; Edmond J Yunis
Journal:  Hum Immunol       Date:  2006-09-26       Impact factor: 2.850

Review 2.  Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome.

Authors:  Vito Racanelli; Tobias Manigold
Journal:  Clin Immunol       Date:  2007-05-31       Impact factor: 3.969

Review 3.  Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.

Authors:  A Moretta; D Pende; F Locatelli; L Moretta
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

Review 4.  Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome.

Authors:  Viviana Romero; Jose Azocar; Joaquin Zúñiga; Olga P Clavijo; Daniel Terreros; Xiangjun Gu; Zaheed Husain; Raymond T Chung; Christopher Amos; Edmond J Yunis
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

Review 5.  Hepatitis C virus infection: molecular pathways to metabolic syndrome.

Authors:  Muhammad Y Sheikh; Jinah Choi; Ishtiaq Qadri; Jacob E Friedman; Arun J Sanyal
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

6.  Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.

Authors:  Karina L McQueen; Kristel M Dorighi; Lisbeth A Guethlein; Ruby Wong; Bharati Sanjanwala; Peter Parham
Journal:  Hum Immunol       Date:  2007-03-12       Impact factor: 2.850

Review 7.  Hepatitis C virus and type 2 diabetes.

Authors:  Francesco Negro; Mahnaz Alaei
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

8.  Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.

Authors:  Viviana Romero; Joaquin Zúñiga; Jose Azocar; Olga P Clavijo; Daniel Terreros; Hassan Kidwai; Janardan P Pandey; Edmond J Yunis
Journal:  Mol Immunol       Date:  2008-07-15       Impact factor: 4.407

9.  Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.

Authors:  A Alba; R Planas; X Clemente; J Carrillo; R Ampudia; M-C Puertas; X Pastor; E Tolosa; R Pujol-Borrell; J Verdaguer; M Vives-Pi
Journal:  Clin Exp Immunol       Date:  2008-01-08       Impact factor: 4.330

Review 10.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Authors:  Barbara Rehermann
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.